Background: Chronic stable coronary artery disease (SCAD) is a general term for all kinds of coronary artery disease (CAD), which includes patients with chronic stable angina, old myocardial infarctions, and also stable condition after revascularization (i.e., percutaneous coronary intervention, coronary artery bypass graft). According to 2012 AHA/ACC guidelines, the objective of the treatment for SCAD is to maintain or recover patients' exercise tolerance, quality of life, and avoid complication like heart failure, so as to decrease mortality, eliminate symptoms, and avoid adverse reactions. Traditional Chinese medicine (TCM) has 2000 years of history in managing CAD and has its advantages in improving quality of life. Using scientific method to evaluate, demonstrate, and conclude the clinical curative effect of TCM is an extremely important task for both TCM and integrative Chinese and Western medicine in the treatment of CAD.
Introduction
Chronic stable coronary artery disease (SCAD) is a general term for all kinds of coronary artery disease (CAD), which includes patients with chronic stable angina, old myocardial infarctions, and also stable condition after revascularization (i.e., percutaneous coronary intervention [PCI] , coronary artery bypass graft [CABG] ). According to 2012 AHA/ACC guidelines, the objective of the treatment for SCAD is to maintain or recover patients' exercise tolerance, quality of life, and avoid complication like heart failure, so as to decrease mortality, eliminate symptoms and avoid adverse reactions.
Traditional Chinese medicine (TCM) has 2000 years of history in managing CAD and has its advantages in improving quality of life. Using scientific method to evaluate, demonstrate, and conclude the clinical curative effect of TCM is an extremely important task for both TCM and integrative Chinese and Western medicine in the treatment of CAD. Recent researches mainly focus on certain types or some certain physiopathology stages of CAD while they're not comprehensive. Worse will, different regions experts have their own diagnosis and treatment plans. There is a lack of unified syndrome differentiation and prescriptions plan for the chronic stable CAD and not enough attention has been paid to TCM despite it having many advantages in improving quality of life in these patients. Considering all the above, this research studied past syndromes' research results and real clinical effective chronic SCAD cases. Cases were analyzed and explored, effective cases were filtered, syndrome differentiation of the prescriptions was refined, thus building a TCM diagnosis and treatment information database.
Methods
The main purpose of this research is to build a TCM diagnosis and treatment database for chronic stable CAD, to summarize the regulation of TCM medicine usage and the effect of the medication in chronic stable CAD, to formulate a syndrome differentiation determined medicine plan based on the improvement of life quality in chronic stable CAD patients (Fig. 1) . This research is registered in Chinese clinical trial registry on december 2, 2016, http://www.chictr.org.cn/showproj.aspx?proj=16534.
This research is to collect real effective cases from authoritative TCM cardiologists' clinic, so as to build a TCM diagnosis and treatment information database that involves 2000 patients. The cases will be analyzed and summarized to conclude the pattern of TCM usage and the effect of use, thus formulating a TCM treatment plan based on syndrome differentiation to improve the quality of life in the chronic SCAD patients. To complete this project, following 4 steps are needed:
1. Standardized medicine usage plan for different syndromes.
Based on the TCM syndromes' research result of 8129 CAD patients from 40 integrated hospitals of China, common syndromes have been determined as: qi deficiency, blood stasis, phlegm retention, yin deficiency, qi stagnation, yang deficiency, accumulation of sthenia-heat and coagulated cold syndrome. Based on the literature review and experts' questionnaires, frequently used medicine database has been build and the range of medicine usage has been defined. clinical diagnosis and treatment. After analyzing the effective and invalid cases, the relationship of TCM characteristics between the medicine-disease, medicine-syndrome, and medicine-symptom was summarized. This is to further refine the characteristics of TCM syndrome differentiation to establish a SCAD treatment plan.
Research subjects
Research subjects are 2000 patients with chronic SCAD from 32 different top-3 hospitals of china. Guideline for diagnosis and treatment of patients with chronic stable angina, [1] 2010 Chinese specialists consensus on management on chronic SCAD, [2] 2013 ESC guidelines on the management of SCAD, [3] 2014 ACC/AHA/AATS/PCNA/SCAI/ STS focused update of the Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease. [4] 2.2.2. TCM diagnostic criteria. TCM diagnostic criteria was fixed with reference to 1990 TCM syndromes differentiation treatment criteria on coronary artery disease set by Cardiovascular Society Branch of Chinese and Western Combination Union, [5] 1997 national standard of the People's Republic of China Clinic terminology of traditional Chinese medical diagnosis and treatment-Syndromes, [6] principles of guideline on new Chinese medicine clinical research, [7] diagnostics of Chinese medicine, [8] TCM internal medicine, [9] and the experts questionnaire about special TCM syndromes of CAD around China.
Inclusion criteria
Diagnose as chronic SCAD at first visit. Heart function classification between II∼III (CCS). Be willing to accept Chinese herbal decoction. Sign an informed consent.
Exclusion criteria
Suffer from acute myocardial infarction, unstable angina or prior revascularization (i.e., PCI, CABG) in the latest 60 days. Have such diseases as follows: refractory hypertension; severe arrhythmia (atrial fibrillation with rapid ventricular response, atrial flutter, paroxysmal ventricular tachycardia, among others); pulmonary heart disease, rheumatic heart disease, myocarditis, cardiomyopathy, aortic dissection, and pulmonary embolism. Hyperthyreosis, cervical spondylosis, gallbladder-cardiac syndrome, gastroesophageal reflux, esophageal hiatal hernia, neurosis, climacteric syndrome, and other diseases which would cause chest pain. Alanine transarninase or serum creatinine more than twice the normal reference value. Hemoglobin <100 g/L or have severe hematological system disease. Malignant tumor. Pregnant, lactating women, or other women have reproductive requirement. Psychosis or cognition impairment person. Taken Chinese medicine decoction in recent 2 weeks. Not take part in any other clinical trial.
Elimination criteria
Patients been found did not meet the trial requirement after enrolled. Patients do not take the medicine as required.
Patients not following up the trial. Patients off the trial without leaving anything useful.
Drop out criteria
Patients off the trial on their own will. Main researcher does not think that the patients are suitable for the trial any longer.
Suspension criteria
Serious safety problem happens in the trial. During the process of the trial, some big problems have been found about the design of this trial, or some deviations happened because of which the effect of the medicine cannot be evaluated. Chief department of the trial decides to undo the trial. Researchers can add some experimental medicine appropriately. Component of Chinese medicine decotions limited in 16 kinds of herbs. Avoid using other types of Chinese medicine product like Chinese patent medicine, Chinese injection medicine, and so on, in the same time. Chinese medicine decoction should use some frequently used medicine instead of uncommon, endangered medicine.
Methods of taking medicine and treatment course.
One packet of warm decoction every morning and evening is taken, wherein treatment course is 7 to 14 days.
2.9. Outcome 2.9.1. Primary outcome 2.9.1.1. EuroQol-5 Dimensions. EuroQol-5 dimensions (EQ-5D) has been accepted as a simple, operable, convenient, and comprehensive tool which includes 2 sections (five-dimension [5D] healthy description system and EQ-VAS). The 5D covers mobility, self-care, usual activities, pain/discomfort, and anxiety/ depression. Every dimension has 5 degrades: easy, a little, medium, difficult, and challenging. EQ-VAS is a 20-cm visual vertical scale, on the top of the scale is 100 point, and it represents the best condition in patient's mind; the bottom is 0 point, which represents the worst condition in patient's mind. 
Laboratory indexes.
Electrocardiograms (ECGs): Record heart rate, heart rhythm, PR interval, QRS interval, QT/QTc, ST segment descending rage, the summation of the ST segment descending rage, T wave inversion, and so on. Dynamic electrocardiogram: Record average heart rate, minimum heart rate(minHr), maximum heart rate(maxHr), supraventricular premature beat (SPB), supraventricular tachycardia, SPB bigeminy, SPB trigeminy, ventricular premature beat (VPB), VPB bigeminy, VPB trigeminy, sinus arrest, number or long pause >2000 ms, and so on. Ultrasonic cardiogram: Ultrasonic cardiogram includes some structure index about cardiac like left ventricular end diastolic diameter , left ventricular end systolic diameter, left atrial diameter, left ventricular diameter, right ventricular, left ventricular posterior wall depth, and interventricular septum; systolic index like left ventricular stroke volume, cardiac output, cardiac index, ejection fraction, and fractional shortening; diastolic index like the ratio of early diastolic E and late diastolic A. Treadmill exercise testing: Record heart rate and blood pressure before and after exercise, level of exercise, metabolic equivalent, exercise lasting time, ST segment descending rage, and frequency of angina and maximum of the ST segment descending rage during exercise.
Safety measurement.
Blood routine test, urine routine test, hepatorenal function test and electrolyte test. Evaluate adverse event.
Evaluate points
Before and after the treatment.
3. Implementation management and quality control
Researchers' training
To make sure the research can goes well, researchers will get some training about content and implementing measure of research through conference, DVD or video and field guidance.
Set-up operating standard
Set up the operating standard of research to make sure the research can proceed successfully.
3.3. Supervise implementation process 3.3.1. Self-check. Each research hospital assigns a quality controller to manage and supervise the dynamic research, which includes updating research progress, managing informed consent form, and filling the CRF. If any problem happened during the implementation, problem can be raised through wechat, telephone, E-mail, or fax to clinical research associate to guarantee the factuality and accuracy of the research result.
Monitoring.
Undertaking hospital is to set up a quality supervision and management group to conduct scheduled or noscheduled monitor to supervise hospital either on the spot or on web, and write inspection report of the process to ensure that the factuality and standardization.
Compliance management
This part involves researchers' and patients' compliance. For researchers, they should fully understand the aim of the research, and be familiar with the implementation. For patients, after they agree to informed consent and cooperate with the research at the same time they will be provided with health education.
Information management
Each specialist's cases will record sequentially. For example: No. 01 expert records his first patient as 01-001; researcher should make sure the data type-in CRF accurately, immediately, and completely; keep the primary information and record; present the CRF after saving the checked data. The record cannot be modified after submission.
3.6. Database management 3.6.1. Questioning database. After CRF has been submitted, inspector will check the CRF and then form a doubt case form (DCF) to list all problems. Researchers will get the send back DCF timely, for each question, they will find a proper explanation, or they'll get DCF second time.
3.6.2. Management database. CRF can be logged in on the spot and a self-check can be done later. Database is updated after submitting checked data. Undertaking research group will assign specific database management people to set up a unique management group, who will in charge of unified management.
3.6.3. Analysis database3.6.3.1. Definite the analysis people.
Intentional analysis: intention to treat collection is the gather of qualified case and unqualified case (except eliminated case). Intention analysis on incomplete cases is to do last observation carried forward (LOCF). Per-protocol analysis: Statistical analysis will done on qualified cases, which complete the research. Safety data analysis: safety data require at least 1 treatment, and then analyzing the adverse event rate. 
Discussion
TCM has 2000 years of history in managing CAD and has its advantages in improving quality of life. Using scientific method to evaluate, demonstrate and conclude the clinical curative effect of TCM is an extremely important task for both TCM and integrative chinese and western medicine in the treatment of CAD. Recent researches mainly focus on certain types or some certain physiopathology stages of CAD while they're not comprehensive. Worse will, different regions experts have their own diagnosis and treatment plan. There is a lack of unified syndrome differentiation and prescriptions plan for the chronic stable CAD and not enough attention has been paid to TCM despite it having many advantages in improving quality of life in these patients. Considering all the above, this research studied past syndromes research results and real clinical effective chronic SCAD cases. Cases were analyzed and explored, effective cases were filtered, syndrome differentiation of the prescriptions was refined, thus building a TCM diagnosis and treatment information database.
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